[1]
Moshkani Farahani, M., Nasiri, A., Salari, M. and Shamsedini, A. 2024. The therapeutic effect of PCSK9 inhibitors on dyslipidemia: one-year follow up. European Journal of Translational Myology. 34, 3 (Sep. 2024). DOI:https://doi.org/10.4081/ejtm.2024.12937.